tirzepatide labs 45mg Tirzepatide 10MG Research Peptide |

doi: 10.1038/sj.ijo.0802583

Recommended Dosage Regimen for Pediatric Patients Aged 12 Years and Older aNot approved as maintenance dosages bSee Dosage Modifications for Adverse Reactions Maintenance Dosage Dosage Modifications for Adverse Reactions Injection: clear, colorless solution available in 5 pre-filled, disposable, single-dose pens: WEGOVY is contraindicated in the following conditions: In mice and rats, semaglutide caused a dose-dependent and treatment-duration-dependent increase in the incidence of thyroid C-cell tumors (adenomas and carcinomas) after lifetime exposure at clinically relevant plasma exposures [see Nonclinical Toxicology (13.1)]

[PubMed: 11684884] 112

Gold et al., 1977